The mechanisms by which nitric-oxide synthases (NOSs) bind and activate oxygen at their P450-type heme active site in order to synthesize nitric oxide from the substrate L-arginine are mostly unknown. To obtain information concerning the structure and properties of the first oxygenated intermediate of the enzymatic cycle, we have used a rapid continuous flow mixer and resonance Raman spectroscopy to generate and identify the ferrous dioxygen complex of the oxygenase domain of nNOS (Fe 2؉ O 2 nNOSoxy). We detect a line at 1135 cm ؊1 in the resonance Raman spectrum of the intermediate formed from 0.6 to 3.0 ms after the rapid mixing of the ferrous enzyme with oxygen that is shifted to 1068 cm
Nitric oxide (NO)1 is an important messenger and an effector molecule involved in numerous physiological functions in the cardiovascular, nervous, and immune systems of mammals (1-3). It is generated by two constitutive isoforms of nitricoxide synthase (NOS) that were first isolated from rat brain (nNOS, NOSI) and vascular endothelium (eNOS, NOSIII) and a cytokine-inducible form that was first isolated from macrophages (iNOS, NOSII) (4). NOSs are homodimers composed of 130 -160-kDa subunits, each comprising an N-terminal oxygenase domain that contains binding sites for heme, L-arginine, and (6R)-5,6,7,8-tetrahydro-L-biopterin (H 4 B) and a C-terminal reductase domain that contains binding sites for NADPH, FAD, and FMN (5-10). As in cytochrome P-450 and chloroperoxidase, the heme of the oxygenase domain is axially coordinated to the thiol group of an endogenous cysteine residue. The electron flow from the reductase domain to the heme domain is controlled by a Ca 2ϩ /calmodulin binding site located in the central portion of each of the NOS isoforms (11).Several lines of evidence indicate that the heme-iron is involved in NO synthesis. NOS activity is inhibited by carbon monoxide (12-14) and by newly synthesized NO molecules, which form a ferrous nitrosyl complex under turnover conditions (15). Moreover, the recently determined structures of the oxygenase domain of iNOS (16, 17) and eNOS (17,18) show that the binding site of the substrate lies above the heme on the distal side. The H 4 B cofactor also binds in the vicinity of the heme, close to the heme propionates in a perpendicular orientation. Both the substrate and H 4 B molecules participate in an extensive hydrogen bond network that includes a heme propionate, water molecules, and several amino acids. The proximity of the L-arginine binding site to the heme is consistent with the interactions of substrates with heme-bound ligands such as CO, NO, and imidazole, which were revealed by optical (19), EPR (20), and resonance Raman spectroscopies (21-23). In addition, the substrates and H 4 B, when present, cause a shift in the spin state of the ferric enzyme (24). It is not clear if H 4 B is also involved in catalysis, although recent results suggest that H 4 B may provide an electron required for oxygen activation (25).The formation of nitric oxide by NOSs involves the NADPHd...